Wells Fargo’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$85.9K Buy
19,037
+1,185
+7% +$5.34K ﹤0.01% 4875
2025
Q1
$79.1K Buy
17,852
+394
+2% +$1.75K ﹤0.01% 4769
2024
Q4
$137K Buy
17,458
+6,131
+54% +$48K ﹤0.01% 4531
2024
Q3
$149K Sell
11,327
-449
-4% -$5.9K ﹤0.01% 4376
2024
Q2
$142K Sell
11,776
-239
-2% -$2.89K ﹤0.01% 4379
2024
Q1
$195K Buy
12,015
+1,582
+15% +$25.7K ﹤0.01% 4119
2023
Q4
$71.2K Buy
10,433
+2,202
+27% +$15K ﹤0.01% 4693
2023
Q3
$44.9K Sell
8,231
-6,387
-44% -$34.8K ﹤0.01% 4884
2023
Q2
$99.3K Buy
14,618
+7,549
+107% +$51.3K ﹤0.01% 4777
2023
Q1
$35.4K Buy
+7,069
New +$35.4K ﹤0.01% 5056
2022
Q4
Sell
-1,291
Closed -$18K 7403
2022
Q3
$18K Sell
1,291
-242
-16% -$3.37K ﹤0.01% 5133
2022
Q2
$23K Sell
1,533
-16,354
-91% -$245K ﹤0.01% 5103
2022
Q1
$212K Sell
17,887
-11,078
-38% -$131K ﹤0.01% 4647
2021
Q4
$470K Sell
28,965
-13,158
-31% -$214K ﹤0.01% 4402
2021
Q3
$1.2M Buy
42,123
+25,523
+154% +$729K ﹤0.01% 3868
2021
Q2
$562K Buy
16,600
+2,226
+15% +$75.4K ﹤0.01% 4295
2021
Q1
$435K Sell
14,374
-12,511
-47% -$379K ﹤0.01% 4456
2020
Q4
$1.33M Buy
26,885
+10,461
+64% +$518K ﹤0.01% 3751
2020
Q3
$632K Sell
16,424
-1,884
-10% -$72.5K ﹤0.01% 4080
2020
Q2
$791K Buy
18,308
+5,720
+45% +$247K ﹤0.01% 3895
2020
Q1
$329K Buy
12,588
+1,606
+15% +$42K ﹤0.01% 4220
2019
Q4
$343K Sell
10,982
-15,690
-59% -$490K ﹤0.01% 4532
2019
Q3
$695K Buy
26,672
+7,469
+39% +$195K ﹤0.01% 4044
2019
Q2
$438K Buy
19,203
+15,526
+422% +$354K ﹤0.01% 4348
2019
Q1
$96K Buy
3,677
+77
+2% +$2.01K ﹤0.01% 5060
2018
Q4
$70K Buy
+3,600
New +$70K ﹤0.01% 5161